SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Transamerica Funds – ‘NSAR-B’ for 10/31/17 – ‘EX-99.77B ACCT LTTR’

On:  Wednesday, 12/27/17, at 5:10pm ET   ·   Effective:  12/27/17   ·   For:  10/31/17   ·   Accession #:  1410368-17-1895   ·   File #:  811-04556

Previous ‘NSAR-B’:  ‘NSAR-B/A’ on 1/13/17 for 10/31/16   ·   Next & Latest:  ‘NSAR-B’ on 2/27/18 for 12/31/17

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/27/17  Transamerica Funds                NSAR-B     10/31/17   13:334K                                   State Street Bank … DeptTransamerica Asset Allocation – Conservative Portfolio A (ICLAX) — Advisor (TACVX) — B (ICLBX) — C (ICLLX) — Class T1 (TACQX) — I (TACIX) — R (ICVRX)Transamerica Asset Allocation – Growth Portfolio A (IAAAX) — Advisor (TAGVX) — B (IAABX) — C (IAALX) — Class T1 (TAGTX) — I (TAGIX) — R (IGWRX)Transamerica Asset Allocation – Moderate Growth Portfolio A (IMLAX) — Advisor (TMGQX) — B (IMLBX) — C (IMLLX) — Class T1 (TMGUX) — I (TMGIX) — R (IMGRX)Transamerica Asset Allocation – Moderate Portfolio A (IMOAX) — Advisor (TMMVX) — B (IMOBX) — C (IMOLX) — Class T1 (TMMTX) — I (TMMIX) — R (IMDRX)Transamerica Asset Allocation Intermediate Horizon R (TAARX) — R4 (TAAFX)Transamerica Asset Allocation Long Horizon R (TALRX) — R4 (TALFX)Transamerica Asset Allocation Short Horizon R (TSHRX) — R4 (TSHFX)Transamerica Balanced II I3 (TBLTX) — R (TBLRX)Transamerica Bond A (IDITX) — Advisor (TAFKX) — B (IFLBX) — C (IFLLX) — Class T1 (TFXTX) — I (TFXIX) — I2R6 (TAFLX)Transamerica Bond I2R6 (TABSX)Transamerica Capital Growth A (IALAX) — Advisor (TACGX) — B (IACBX) — C (ILLLX) — Class T1 (TFOTX) — I (TFOIX) — I2Transamerica ClearTrack 2015 R1 (TCFTX) — R6 (TDKTX)Transamerica ClearTrack 2020 R1 (TCHTX) — R6 (TCSUX)Transamerica ClearTrack 2025 R1 (TDITX) — R6 (TDOTX)Transamerica ClearTrack 2030 R1 (TDFTX) — R6 (TDHTX)Transamerica ClearTrack 2035 R1 (TCETX) — R6 (TCHDX)Transamerica ClearTrack 2040 R1 (TCRTX) — R6 (TCKTX)Transamerica ClearTrack 2045 R1 (TCPTX) — R6 (TCOTX)Transamerica ClearTrack 2050 R1 (TRNTX) — R6 (TCMTX)Transamerica ClearTrack 2055 Class R1 (TCTOX) — Class R6 (TCTSX)Transamerica ClearTrack 2060 Class R1 (TCSOX) — Class R6 (TCSSX)Transamerica ClearTrack Retirement Income R1 (TCITX) — R6 (TCJTX)Transamerica Concentrated Growth A (TORAX) — Advisor (TACNX) — C (TCCGX) — Class T1 (TORQX) — I (TOREX) — I2Transamerica Core Bond I2Transamerica Core Bond (formerly Transamerica Intermediate Bond) I2I3 (TMBTX) — R (TMBRX) — R4 (TMBFX)Transamerica Developing Markets Equity I2 (TDMIX)Transamerica Dynamic Allocation A (ATTRX) — C (CTTRX) — Class T1 (ATTTX) — I (ITTOX)Transamerica Dynamic Income A (IGTAX) — Advisor (IGTVX) — C (IGTCX) — Class T1 (IGTTX) — I (IGTIX)Transamerica Emerging Markets Debt A (EMTAX) — Advisor (TAETX) — C (EMTCX) — Class T1 (EMTTX) — I (EMTIX) — I2R6 (TAEDX)Transamerica Emerging Markets Equity A (AEMTX) — Advisor (TAEEX) — C (CEMTX) — Class T1 (AEMQX) — I (IEMTX) — I2Transamerica Energy Infrastructure A (TMLAX) — Advisor (TAMLX) — C (TMCLX) — Class T1 (TMLTX) — I (TMLPX) — I2Transamerica Event Driven Advisor (TAEVX) — I (TENIX) — I2Transamerica Floating Rate A (TFLAX) — C (TFLCX) — Class T1 (TFLTX) — I (TFLIX) — I2Transamerica Global Equity A (IMNAX) — Advisor (TAGQX) — B (IMNBX) — C (IMNCX) — Class T1 (TMUTX) — I (TMUIX) — R6 (TAGEX)Transamerica Global Long/Short Equity A (TAEAX) — AdvisorClass T1I (TAEIX) — I2Transamerica Global Multifactor Macro I2Transamerica Global Real Estate Securities I2 (TRSIX)Transamerica Government Money Market A (IATXX) — B (IBTXX) — C (IMLXX) — I (TAMXX) — I2I3 (TGTXX) — R2 (TGRXX) — R4 (TFGXX)Transamerica Growth I2 (TJNIX) — R6 (TAGOX)Transamerica High Quality Bond I3 (TBDTX) — R (TBDRX) — R4 (TBDFX)Transamerica High Yield Bond A (IHIYX) — Advisor (TAGLX) — B (INCBX) — C (INCLX) — Class T1 (TAHWX) — I (TDHIX) — I2I3 (TAHTX) — R (TAHRX) — R4 (TAHFX) — R6 (TAHBX)Transamerica High Yield Muni A (THAYX) — C (THCYX) — Class T1 (THCTX) — I (THYIX) — I2 (THYTX)Transamerica Inflation Opportunities A (TIOAX) — C (TIOCX) — Class T1 (TIOWX) — I (ITIOX) — I2R6 (RTIOX)Transamerica Inflation-Protected Securities I3 (TPRTX) — R (TPRRX) — R4 (TPRFX)Transamerica Intermediate Muni A (TAMUX) — Advisor (TAITX) — C (TCMUX) — Class T1 (TAMTX) — I (TIMUX) — I2 (TIMTX)Transamerica International Equity A (TRWAX) — Advisor (TAIQX) — C (TRWCX) — Class T1 (TRWWX) — I (TSWIX) — I2 (TRWIX) — I3 (TRWTX) — R (TRWRX) — R4 (TRWFX) — R6 (TAINX)Transamerica International Focus I2Transamerica International Small Cap I2Transamerica International Small Cap Value I (TISVX) — I2Transamerica Large Cap Value A (TWQAX) — Advisor (TALPX) — C (TWQCX) — I (TWQIX) — I2 (TWQZX) — R6 (TALCX) — T1 (TWQTX)Transamerica Large Core ESG I3 (TLATX) — R (TLARX) — R4 (TLAFX)Transamerica Large Growth I3 (TGWTX) — R (TGWRX) — R4 (TGWFX)Transamerica Large Value Opportunities I3 (TLOTX) — R (TLORX) — R4 (TLOFX)Transamerica Long/Short Strategy I2Transamerica Managed Futures Strategy I2Transamerica Mid Cap Growth A (MCGAX) — Advisor (TAMGX) — C (MGTCX) — Class T1 (IMCTX) — I (IMCGX) — I2I3 (TMITX) — R (TMIRX) — R4 (TMIFX)Transamerica Mid Cap Value I2Transamerica Mid Cap Value Opportunities A (MCVAX) — Advisor (TAMOX) — C (MCVCX) — Class T1 (MVTTX) — I (MVTIX) — I2I3 (TOTTX) — R (TOTRX) — R4 (TOTFX) — R6 (MVTRX)Transamerica Multi-Asset Income A (TASHX) — Advisor (TASKX) — C (TCSHX) — Class T1 (TCSWX) — I (TSHIX) — I2Transamerica Multi-Cap Growth A (ITSAX) — Advisor (TAMHX) — B (ITCBX) — C (ITSLX) — Class T1 (TGPTX) — I (TGPIX) — I2Transamerica Multi-Managed Balanced A (IBALX) — Advisor (IBAVX) — B (IBABX) — C (IBLLX) — Class T1 (IBATX) — I (TBLIX) — R6 (TAMMX)Transamerica Multi-Manager Alternative Strategies Portfolio A (IMUAX) — C (IMUCX) — Class T1 (IMUTX) — I (TASIX) — R6 (TAMAX)Transamerica Short-Term Bond A (ITAAX) — Advisor (TASBX) — C (ITACX) — Class T1 (ITATX) — I (TSTIX) — I2 (TSIWX) — R6 (TASTX)Transamerica Small Cap Core A (SCCAX) — Advisor (TASOX) — C (SCCCX) — Class T1 (ISMQX) — I (ISMTX) — I2I3 (TCCTX) — R (TCCRX) — R4 (TCCFX)Transamerica Small Cap Growth A (ASGTX) — Advisor (TASPX) — C (CSGTX) — Class T1 (RTSTX) — I (ISCGX) — I2 (TSPIX) — I3 (TSPTX) — R (TSPRX) — R4 (TSPFX) — R6 (RTSGX)Transamerica Small Cap Value A (TSLAX) — Advisor (TASLX) — C (TSLCX) — Class T1 (TSLWX) — I (TSLIX) — I2I3 (TSLTX) — R (TRSLX) — R4 (TSLFX) — R6 (TSLRX)Transamerica Small/Mid Cap Value A (IIVAX) — Advisor (TASDX) — B (IIVBX) — C (IIVLX) — Class T1 (TASWX) — I (TSVIX) — I2 (TSMVX) — R6 (TASMX)Transamerica Sustainable Equity Income A (TDFAX) — Advisor (TADVX) — C (TDFCX) — Class T1 (TADTX) — I (TDFIX) — I2 (TRDIX) — R6 (TADFX)Transamerica Total Return I2Transamerica Unconstrained Bond Advisor (TAUNX) — I (TUNIX) — I2Transamerica US Growth A (TADAX) — Advisor (TAUGX) — B (TADBX) — C (TADCX) — Class T1 (TJNTX) — I (TDEIX) — I2T (TWMTX)

Annual Report by an Investment Company   —   Form N-SAR   —   ICA’40
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: NSAR-B      10.31.17 Final Nsar                                  238    971K 
13: EX-99.77B ACCT LTTR  Audit Control Letter                          3±    14K 
12: EX-99.77M MERGERS  Mergers                                         3±    13K 
 3: EX-99.77O RULE 10F-3  Bond (Loomis)                                2±    10K 
 4: EX-99.77O RULE 10F-3  Capital Growth (Morgan Stanley)              3±    13K 
 5: EX-99.77O RULE 10F-3  Core Bond (Jpm)                             99±   407K 
 6: EX-99.77O RULE 10F-3  Core Bond (Jpm)                              6±    20K 
 7: EX-99.77O RULE 10F-3  Long-Short Strategy (Jpm)                    1      7K 
 8: EX-99.77O RULE 10F-3  Long-Short Strategy (Jpm)                    3±    12K 
 9: EX-99.77O RULE 10F-3  Multi-Managed Balanced (Jpm)                 1      7K 
10: EX-99.77O RULE 10F-3  Multi-Managed Balanced (Jpm)                 3±    12K 
11: EX-99.77Q1 OTHR EXHB  17E-1 - Affiliated Brokers                   1      6K 
 2: EX-7        7C Attachment for Series Number Over 99                2±     8K 


‘EX-99.77B ACCT LTTR’   —   Audit Control Letter



Report of Independent Registered Public Accounting Firm To the Board of Trustees & Shareholders of Transamerica Funds: In planning and performing our audits of the financial statements of ClearTrack 2015, ClearTrack 2020, ClearTrack 2025, ClearTrack 2030, ClearTrack 2035, ClearTrack 2040, ClearTrack 2045, ClearTrack 2050, ClearTrack 2055, ClearTrack 2060, ClearTrack Retirement Income, Transamerica Asset Allocation - Conservative Portfolio, Transamerica Asset Allocation - Growth Portfolio, Transamerica Asset Allocation Intermediate Horizon, Transamerica Asset Allocation Long Horizon, Transamerica Asset Allocation - Moderate Growth Portfolio, Transamerica Asset Allocation - Moderate Portfolio, Transamerica Multi- Manager Alternative Strategies Portfolio, Transamerica Asset Allocation Short Horizon, Transamerica Balanced II, Transamerica Bond, Transamerica Capital Growth, Transamerica Concentrated Growth, Transamerica Core Bond, Transamerica Developing Markets Equity, Transamerica Dividend Focused, Transamerica Dynamic Allocation, Transamerica Dynamic Income, Transamerica Emerging Markets Debt, Transamerica Emerging Markets Equity, Transamerica Event Driven, Transamerica Flexible Income, Transamerica Floating Rate, Transamerica Global Equity, Transamerica Global Real Estate Securities, Transamerica Government Money Market, Transamerica Growth, Transamerica High Quality Bond, Transamerica High Yield Bond, Transamerica High Yield Muni, Transamerica Inflation-Protected Securities, Transamerica Inflation Opportunities, Transamerica Intermediate Bond, Transamerica Intermediate Muni, Transamerica International Equity, Transamerica International Equity Opportunities, Transamerica International Small Cap, Transamerica International Small Cap Value, Transamerica Large Cap Value, Transamerica Large Core, Transamerica Large Growth, Transamerica Large Value Opportunities, Transamerica Long/Short Strategy, Transamerica Mid Cap Growth, Transamerica Mid Cap Value, Transamerica Mid Cap Value Opportunities, Transamerica MLP & Energy Income, Transamerica Multi-Cap Growth, Transamerica Multi- Managed Balanced, Transamerica Short-Term Bond, Transamerica Small Cap Core, Transamerica Small Cap Growth, Transamerica Small Cap Value, Transamerica Small/Mid Cap Value, Transamerica Strategic High Income, Transamerica Total Return, Transamerica Unconstrained Bond and Transamerica US Growth, and the consolidated financial statements of Transamerica Global Multifactor Macro and Transamerica Managed Futures Strategy (seventy of the Funds comprising the Transamerica Funds, collectively, the "Funds") as of and for the year or periods ended October 31, 2017, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Funds' internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-SAR, but not for the purpose of expressing an opinion on the effectiveness of the Funds' internal control over financial reporting. Accordingly, we express no such opinion. The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds' internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Funds' internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of October 31, 2017. This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. Boston, Massachusetts December 27, 2017

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘NSAR-B’ Filing    Date    Other Filings
Filed on / Effective on:12/27/17
For Period end:10/31/1724F-2NT,  N-CSR,  N-CSR/A,  N-MFP2
 List all Filings 
Top
Filing Submission 0001410368-17-001895   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 3:57:48.7am ET